您好,欢迎来到佐思信息
全国服务热线:
400-009-0050
佐思信息专注支持企业决策
您当前的位置:首页>>产业观察>>生物科技>> 全球免疫化学试剂、仪器以及检测市场规模将在2015年达到181亿美元

全球免疫化学试剂、仪器以及检测市场规模将在2015年达到181亿美元

发表于2013-4-1 12:05:35|Tag:免疫试剂immunochemistry reagent

 

全球免疫化学试剂、仪器以及检测市场规模将在2015年达到181亿美元。全球免疫化学市场将快速增长,得益于潜在的巨大市场需求。需求将伴随着针对新的检测标的物的研发,全球老龄化以及先进技术发展而增长。免疫化学是全球体外诊断(IVD)市场中最大的细分市场,免疫化学检测主要包括贫血/微量元素检测、特殊疾病检测、毒品/毒理性检测、治疗药物检测、内分泌检测、快速检测等,业内主要竞争者包括瑞士罗氏Roche, 西门子医疗Siemens Healthcare, 雅培Abbott, 丹纳赫Danaher, 强生医疗Ortho Clinical Diagnostics (J&J) 以及 生物梅里埃bioMerieux等公司,除了上述大企业外,这个市场还有许多拥有许多创新性产品的小型公司,而中国和印度是被认为市场潜力最大的两个市场。
 
The global market for immunochemistry reagents, analysers and test kits will reach $18.1bn in 2015. The immunochemistry market will experience strong growth, driven by an increase in demand for diagnostic testing. This demand, along with increased research activity for identifying new analytes, will be driven by an aging global population and technological advances. The Immunochemistry market is one of the largest sectors of the global in vitro diagnostics (IVD) market. This sector encompasses all reagents, instruments and test kits to conduct diagnoses outside the living organism.
 
As a mature sector of the IVD market, growth will be steady and continuous. Due to the maturity of the market, clinicians are likely to opt for immunochemistry products over other new technologies. High incidences of cancer, infectious diseases and cardiovascular diseases, along with a global aging population will fuel demand for immunochemistry based tests. The immunochemistry market will also benefit from strong growth in emerging countries, as these markets remain relatively under penetrated. Countries like China and India offer huge opportunities, especially due to their vast patient population.
 
Despite the market being dominated by a few large medical device manufacturers, there are several small companies manufacturing niche and innovative products. Market growth will be driven by an increasing demand for automated systems, especially from developing nations. The most obvious benefit of increasing automation is the reduction of human error and overall costs. Automation has become important in the context of budget restriction and staff reduction. However, the immunochemistry diagnostic market will face increasing competition from other diagnostic technologies and so, future growth will depend on the availability of more clinical evidence to prove effectiveness of immunochemistry tests. The increasing competition from other technologies will also require market participants to differentiate their products to remain competitive.
 
The immunochemistry reagents and tests kits subsectors:
 
Anaemia/Vitamin tests
Disease specific tests
Drugs of abuse/toxicology tests
Therapeutic drug monitoring
Endocrinology tests
Rapid tests
 
The leading companies, including Roche, Siemens Healthcare, Abbott, Danaher, Ortho Clinical Diagnostics (J&J) and bioMerieux.

关于我们|联系我们|常见问题|服务项目|购买流程
2005-2013 All rights reserved.京ICP备05069564号-4 京公网安备110108 02010359号
全国服务热线:400-009-0050北京:010-82863481上海:021-64871266

在线客服系统